• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非洲 COVID-19 死亡率低:一个悖论?

Africa's low COVID-19 mortality rate: A paradox?

机构信息

Department of Medicine, Federal Medical Center Azare, Bauchi State, Nigeria.

出版信息

Int J Infect Dis. 2021 Jan;102:118-122. doi: 10.1016/j.ijid.2020.10.038. Epub 2020 Oct 16.

DOI:10.1016/j.ijid.2020.10.038
PMID:33075535
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7566670/
Abstract

BACKGROUND

COVID-19 continues to spread worldwide, with high numbers of fatalities reported first in China, followed by even higher numbers in Italy, Spain, the UK, the USA, and other advanced countries. Most African countries, even with their less advanced healthcare systems, continue to experience lower COVID-19 mortality rates. This was the case as the pandemic reached its first peak, plateaued, and declined. It is currently rising again in some countries, though not as rapidly as before. This study aimed to determine the predictors of COVID-19 mortality rate. This may help explain why Africa's COVID-19 mortality rate is, ironically, lower than that of more advanced countries with better health systems. This will also assist various governments in balancing their COVID-19 restrictive and socioeconomic measures.

METHODOLOGY

This was an analytical review, which used pre-COVID-19 era population data and current COVID-19 mortality figures to determine predictors of COVID-19 mortality rates. Pearson's correlation was used to test the association between some population variables and COVID-19 mortality rates. Next, stepwise multiple regression analysis was used to determine significant predictors of COVID-19 mortality rates.

RESULTS

Significant positive predictors of COVID-19 mortality rate included pre-COVID-19 era '65-yr+ mortality %' (R = 0.574, B = 2.86, p < 0.001), population mean age (R = 0.570, B = 4.77, p = 0.001), and life expectancy (R = 0.524, B = 1.67, p = 0.008). Pre-COVID-19 era CVD death rate was a negative predictor of COVID-19 mortality rate (R = 0.524, B = -0.584, p = 0.012).

CONCLUSION

Africa's lower COVID-19 mortality rate is due to the lower population mean age, lower life expectancy, lower pre-COVID-19 era '65yr+ mortality rate', and smaller pool of people surviving and living with cardiovascular diseases.

摘要

背景

COVID-19 继续在全球范围内传播,中国首先报告了大量死亡病例,随后意大利、西班牙、英国、美国和其他发达国家的死亡病例甚至更高。大多数非洲国家,即使其医疗保健系统不太先进,COVID-19 的死亡率继续保持较低水平。在大流行达到第一个高峰、稳定和下降时,情况就是如此。目前,一些国家的 COVID-19 死亡率再次上升,尽管没有以前那么快。本研究旨在确定 COVID-19 死亡率的预测因素。这可以帮助解释为什么具有更好卫生系统的更先进国家的 COVID-19 死亡率反而较低。这也将帮助各国政府在平衡 COVID-19 限制和社会经济措施方面发挥作用。

方法

这是一项分析性综述,使用 COVID-19 前时代的人口数据和当前 COVID-19 死亡率数据来确定 COVID-19 死亡率的预测因素。使用 Pearson 相关系数来检验一些人口变量与 COVID-19 死亡率之间的关联。然后,使用逐步多元回归分析来确定 COVID-19 死亡率的显著预测因素。

结果

COVID-19 死亡率的显著正预测因素包括 COVID-19 前时代的“65 岁以上死亡率%”(R=0.574,B=2.86,p<0.001)、人口平均年龄(R=0.570,B=4.77,p=0.001)和预期寿命(R=0.524,B=1.67,p=0.008)。COVID-19 前时代的 CVD 死亡率是 COVID-19 死亡率的负预测因素(R=0.524,B=-0.584,p=0.012)。

结论

非洲 COVID-19 死亡率较低是由于人口平均年龄较低、预期寿命较低、COVID-19 前时代“65 岁以上死亡率”较低,以及患有心血管疾病并幸存下来的人群较小。

相似文献

1
Africa's low COVID-19 mortality rate: A paradox?非洲 COVID-19 死亡率低:一个悖论?
Int J Infect Dis. 2021 Jan;102:118-122. doi: 10.1016/j.ijid.2020.10.038. Epub 2020 Oct 16.
2
COVID-19 in African Countries versus other World Regions: A Review.非洲国家与世界其他地区的新冠疫情:综述
Afr J Reprod Health. 2020 Jun;24(s1):125-141. doi: 10.29063/ajrh2020/v24i2s.17.
3
The Determinants of the Low COVID-19 Transmission and Mortality Rates in Africa: A Cross-Country Analysis.非洲 COVID-19 传播率和死亡率低的决定因素:跨国分析。
Front Public Health. 2021 Oct 21;9:751197. doi: 10.3389/fpubh.2021.751197. eCollection 2021.
4
Addressing Africa's pandemic puzzle: Perspectives on COVID-19 transmission and mortality in sub-Saharan Africa.解决非洲的大流行难题:撒哈拉以南非洲地区 COVID-19 传播和死亡率的观点。
Int J Infect Dis. 2021 Jan;102:483-488. doi: 10.1016/j.ijid.2020.09.1456. Epub 2020 Sep 30.
5
Association between ageing population, median age, life expectancy and mortality in coronavirus disease (COVID-19).人口老龄化、中位数年龄、预期寿命与冠状病毒病(COVID-19)死亡率之间的关联。
Aging (Albany NY). 2020 Nov 24;12(24):24570-24578. doi: 10.18632/aging.104193.
6
COVID deaths in South Africa: 99 days since South Africa's first death.南非新冠死亡病例:南非首例死亡 99 天后。
S Afr Med J. 2020 Oct 1;110(11):1093-1099.
7
The association between malaria prevalence and COVID-19 mortality.疟疾发病率与 COVID-19 死亡率之间的关联。
BMC Infect Dis. 2021 Sep 19;21(1):975. doi: 10.1186/s12879-021-06701-8.
8
Mental health nurses in South Africa's public rural primary care settings: a human resource crisis.南非农村公共基层医疗环境中的精神科护士:一场人力资源危机。
Rural Remote Health. 2016 Jul-Sep;16(3):3865. Epub 2016 Jul 18.
9
Global, regional, and national under-5 mortality, adult mortality, age-specific mortality, and life expectancy, 1970-2016: a systematic analysis for the Global Burden of Disease Study 2016.全球、区域和国家 5 岁以下儿童死亡率、成人死亡率、特定年龄死亡率和预期寿命,1970-2016 年:2016 年全球疾病负担研究的系统分析。
Lancet. 2017 Sep 16;390(10100):1084-1150. doi: 10.1016/S0140-6736(17)31833-0.
10
Variation in the COVID-19 infection-fatality ratio by age, time, and geography during the pre-vaccine era: a systematic analysis.在疫苗接种前时代,按年龄、时间和地理位置划分的 COVID-19 感染病死率变化:系统分析。
Lancet. 2022 Apr 16;399(10334):1469-1488. doi: 10.1016/S0140-6736(21)02867-1. Epub 2022 Feb 24.

引用本文的文献

1
High seroprevalence of anti-SARS-CoV-2 antibodies in the capital of Chad.乍得首都抗新冠病毒抗体的高血清阳性率。
J Public Health Afr. 2023 Jan 11;13(4):2255. doi: 10.4081/jphia.2022.2255. eCollection 2022 Dec 31.
2
Early pandemic associations of latitude, sunshine duration, and vitamin D status with COVID-19 incidence and fatalities: A global analysis of 187 Countries.大流行早期纬度、日照时长和维生素D状况与新冠肺炎发病率及死亡率的关联:对187个国家的全球分析
PLOS Glob Public Health. 2025 Jul 28;5(7):e0004074. doi: 10.1371/journal.pgph.0004074. eCollection 2025.
3
The impact of COVID-19: consequences of a 3-Year struggle in Iran.新冠疫情的影响:伊朗三年抗疫的后果
BMC Infect Dis. 2025 Apr 18;25(1):558. doi: 10.1186/s12879-025-10955-x.
4
Enterococcus and Eggerthella species are enriched in the gut microbiomes of COVID-19 cases in Uganda.在乌干达,粪肠球菌和埃格特菌属在新冠肺炎病例的肠道微生物群中富集。
Gut Pathog. 2025 Feb 4;17(1):9. doi: 10.1186/s13099-025-00678-4.
5
Cellular immune response to SARS-CoV-2 and clinical presentation in individuals exposed to endemic malaria.细胞免疫对 SARS-CoV-2 的反应和接触地方性疟疾个体的临床表现。
Cell Rep. 2024 Aug 27;43(8):114533. doi: 10.1016/j.celrep.2024.114533. Epub 2024 Jul 24.
6
The evolution of household forgone essential care and its determinants during the COVID-19 pandemic in Nigeria: A longitudinal analysis.新冠疫情期间尼日利亚家庭放弃基本医疗服务的演变及其决定因素:一项纵向分析。
PLoS One. 2024 Apr 2;19(4):e0296301. doi: 10.1371/journal.pone.0296301. eCollection 2024.
7
Economic and social determinants of health care utilization during the first wave of COVID-19 pandemic among adults in Ghana: a population-based cross-sectional study.加纳成年人在 COVID-19 大流行第一波期间卫生保健利用的经济和社会决定因素:一项基于人群的横断面研究。
BMC Public Health. 2024 Feb 13;24(1):455. doi: 10.1186/s12889-024-17912-4.
8
Climate and COVID-19 transmission: a cross-sectional study in Africa.气候与 COVID-19 传播:非洲的一项横断面研究。
Sci Rep. 2023 Oct 31;13(1):18702. doi: 10.1038/s41598-023-46007-0.
9
Key Considerations during the Transition from the Acute Phase of the COVID-19 Pandemic: A Narrative Review.新冠疫情急性期过渡期间的关键考量因素:一项叙述性综述
Vaccines (Basel). 2023 Sep 19;11(9):1502. doi: 10.3390/vaccines11091502.
10
Income inequality and pandemics: insights from HIV/AIDS and COVID-19-a multicountry observational study.收入不平等与大流行病:来自艾滋病毒/艾滋病和 COVID-19 的启示——一项多国观察性研究。
BMJ Glob Health. 2023 Sep;8(9). doi: 10.1136/bmjgh-2023-013703.

本文引用的文献

1
A cross-country database of COVID-19 testing.一个跨越国界的 COVID-19 检测数据库。
Sci Data. 2020 Oct 8;7(1):345. doi: 10.1038/s41597-020-00688-8.
2
The COVID-19 epidemic.新冠疫情。
Trop Med Int Health. 2020 Mar;25(3):278-280. doi: 10.1111/tmi.13383. Epub 2020 Feb 16.
3
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.中国武汉地区 2019 年新型冠状病毒感染患者的临床特征。
Lancet. 2020 Feb 15;395(10223):497-506. doi: 10.1016/S0140-6736(20)30183-5. Epub 2020 Jan 24.